Opportunity timeline
In plain English
ARPA-H is seeking proposals from U.S. small businesses for innovative health-related research under its SBIR and STTR programs. Open topics include fertility testing, bioadhesives, toxin removal using synthetic biology, non-surgical endometriosis treatment, and other ARPA-H technologies. Stage 1 and Stage 2 deadlines vary by topic; the Stage 1 deadline was extended to July 17, 2026, and later amendments revised Stage 2 deadlines for several topics.
About this opportunity
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns (SBCs) that possess the research and development (R&D) expertise to conduct innovative research that will contribute toward ARPA-H mission needs, Small Business Innovation Research (SBIR), and Small Business Technology Transfer (STTR) program objectives. Please see the cover page of the attachment "SBIR_STTR_BAA_FY26" for applicable Stage 1 and Stage 2 deadlines for each open topic. Please see the Attachment H "ARPA-H_SBP_Government_Answered_Questions" for responses to the Q&A period. The purposes of the SBIR and STTR programs are to: (a) stimulate technological innovation; (b)…
Time remaining
Closes Oct 1, 2026
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Emergent Drug Panel-Version 2 (EDP-V2) Kit

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-E61D98

